Edition:
United States

Soligenix Inc (SNGX.OQ)

SNGX.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
4:00pm EDT
Change (% chg)

$-0.04 (-3.08%)
Prev Close
$1.30
Open
$1.36
Day's High
$1.38
Day's Low
$1.25
Volume
17,172
Avg. Vol
22,805
52-wk High
$3.70
52-wk Low
$1.25

Select another date:

Fri, May 11 2018

BRIEF-Soligenix Reports Q1 Loss Per Share Of $0.27

* SOLIGENIX ANNOUNCES RECENT ACCOMPLISHMENTS AND FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning

* SOLIGENIX RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR RIVAX® FOR PREVENTION OF RICIN POISONING Source text for Eikon: Further company coverage:

BRIEF-Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials

* SOLIGENIX - DRIVING TOWARDS KEY INFLECTION POINTS WITH TWO PIVOTAL PHASE 3 CLINICAL TRIALS Source text for Eikon: Further company coverage:

BRIEF-Soligenix Announces US Patent Issuance For Use Of Dusquetide In Oral Mucositis

* SOLIGENIX ANNOUNCES US PATENT ISSUANCE FOR USE OF DUSQUETIDE IN ORAL MUCOSITIS Source text for Eikon: Further company coverage:

Select another date: